Indeed, there is a highly significant correlation between the expression of LGALS9 (the gene encoding Gal9) and CD68 (a classical marker of GB macrophages) expression in patient samples from two distinct glioma cohorts (Fig. S4a). The gene discussed is CD68; the disease is central nervous system cancer.